CMS finalizes 2020 payment rules

CMS has finalized payment rules for 2020, including the Medicare Physician Fee Schedule and the Medicare Hospital Outpatient Prospective Payment System and Ambulatory surgical Center Payment System. The agency originally proposed 2020 payment rule changes in July.

The PFS final rule aims to reduce paperwork burdens for clinicians, according to CMS Administrator Seema Verma. The agency proposed a number of rules that would change coding requirements in an effort to simplify.

One area of contention was a change in the coding requirements for evaluation and management (E/M) services that reflect complexity in patient cases. The proposed changes were met with some backlash from industry groups that argued physicians would see a payment drop by collapsing the levels into just a few categories. CMS decided not to go ahead with this change in the final rule, keeping separate payment rates for each of the office and outpatient E/M visit codes, according to AMGA.

“A team-based approach to care requires an infrastructure to support it,” Jerry Penso, MD, MBA, AMGA president and CEO, said in a statement supporting the final PFS. “It also requires the right policies and a payment system that will maintain that infrastructure. This change goes a long way to helping our members deliver the best possible care.”

However, the association wasn’t all pleased with the final rules. It also expressed disappointment with changes in the Merit-based Incentive Payment System (MIPS), with CMS expecting a Part B payment adjustment of 1.4% for participants in the program finalized. Compared to the 9% payment adjustment allowed by Congress for the 2020 payment year, AMGA doesn’t see the program as a viable way to achieve value-based care for more providers switching from fee for service.

CMS also aimed to give physician assistants greater flexibility under the final rule, increased payment for transitional care management services and added a code specifically for the care management of patients with single, high-risk conditions such as diabetes.

It also expanded access to treatment for opioid use disorder in the face of a national overdose and abuse crisis. Opioid treatment programs will be able to be paid by Medicare for treatment services of beneficiaries beginning in 2020.

Within the hospital OPPS final rule, CMS did not include a proposal to force hospitals to display what they charge for healthcare services. The agency said it may include the requirement in its own rule in the future. The rule is currently under review at the Office of Management and Budget.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.